This Article Full Text Full Text (PDF) All Versions of this Article: 25/2/467    most recent 01.ATV.0000152726.49229.bfv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Remenyi, G. Articles by Dale, G. L. Search for Related Content PubMed PubMed Citation Articles by Remenyi, G. Articles by Dale, G. L.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:467.)
© 2005 American Heart Association, Inc.

Thrombosis

Role of Mitochondrial Permeability Transition Pore in Coated-Platelet Formation

Gyula Remenyi; Robert Szasz; Paul Friese; George L. Dale

From the W.K. Warren Medical Research Institute, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.

Correspondence to George L. Dale, PhD, Department of Medicine; BSEB-330, OU Health Sciences Center, 941 Stanton Young Blvd, Oklahoma City, OK 73104. E-mail george-dale{at}ouhsc.edu

Objective— Coated-platelets are a subset of cells observed during costimulation of platelets with collagen and thrombin. Important characteristics of coated-platelets include retention of multiple -granule proteins and expression of phosphatidylserine on the cell surface. The mitochondrial permeability transition pore (MPTP) is a key step in apoptosis and is suggested to be involved in some forms of platelet activation. The objective of this study was to examine the role of MPTP in the synthesis of coated-platelets.

Methods and Results— Flow cytometric analysis of coated-platelet production was used to examine the impact of pharmacological effectors of MPTP formation. Cyclosporin A, coenzyme Q, and bongkrekic acid all inhibit MPTP formation as well as production of coated-platelets. Phenylarsine oxide and diamide, both potentiators of MPTP formation, stimulate coated-platelet synthesis. Atractyloside, another inducer of MPTP formation, does not affect the percentage of coated-platelets synthesized; however, it does increase the level of phosphatidylserine exposed on the surface of coated-platelets.

Conclusions— These findings indicate that MPTP formation is an integral event in the synthesis of coated-platelets. Although the exact function of the MPTP remains to be determined, these data support a growing body of evidence that apoptosis-associated events are vital components of the platelet activation process.

Formation of coated-platelets involves a complex set of activation events initiated by dual agonist activation. The mitochondrial permeability transition pore (MPTP) is a key intermediate in apoptosis and has been suggested to impact platelet activation. This report demonstrates that MPTP formation is essential to production of coated-platelets.

Key Words: coated-platelet • mitochondrial permeability transition pore • coenzyme Q • phosphatidylserine • cyclosporin A • phenylarsine oxide • diamide

This article has been cited by other articles:

				A. Arachiche, D. Kerbiriou-Nabias, I. Garcin, T. Letellier, and J. Dachary-Prigent Rapid Procoagulant Phosphatidylserine Exposure Relies on High Cytosolic Calcium Rather Than on Mitochondrial Depolarization Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1883 - 1889. [Abstract] [Full Text] [PDF]

				K. H. Lin, G. Hsiao, C. M. Shih, D. S. Chou, and J. R. Sheu Mechanisms of resveratrol-induced platelet apoptosis Cardiovasc Res, August 1, 2009; 83(3): 575 - 585. [Abstract] [Full Text] [PDF]

				S. M. Schoenwaelder, Y. Yuan, E. C. Josefsson, M. J. White, Y. Yao, K. D. Mason, L. A. O'Reilly, K. J. Henley, A. Ono, S. Hsiao, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function Blood, July 16, 2009; 114(3): 663 - 666. [Abstract] [Full Text] [PDF]

				R. Chen, X. Chen, R. G. Salomon, and T. M. McIntyre Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 363 - 371. [Abstract] [Full Text] [PDF]

				F. A. Bozza and A. S. Weyrich Mitochondria push platelets past their prime Blood, March 1, 2008; 111(5): 2496 - 2497. [Full Text] [PDF]

				S. M. Jobe, K. M. Wilson, L. Leo, A. Raimondi, J. D. Molkentin, S. R. Lentz, and J. Di Paola Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis Blood, February 1, 2008; 111(3): 1257 - 1265. [Abstract] [Full Text] [PDF]

				S. A. Maroney, S. L. Haberichter, P. Friese, M. L. Collins, J. P. Ferrel, G. L. Dale, and A. E. Mast Active tissue factor pathway inhibitor is expressed on the surface of coated platelets Blood, March 1, 2007; 109(5): 1931 - 1937. [Abstract] [Full Text] [PDF]